Cargando…

Pharmacogenomics of Prostaglandin and Leukotriene Receptors

Individual genetic background together with environmental effects are thought to be behind many human complex diseases. A number of genetic variants, mainly single nucleotide polymorphisms (SNPs), have been shown to be associated with various pathological and inflammatory conditions, representing po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornejo-García, José A., Perkins, James R., Jurado-Escobar, Raquel, García-Martín, Elena, Agúndez, José A., Viguera, Enrique, Pérez-Sánchez, Natalia, Blanca-López, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030812/ https://www.ncbi.nlm.nih.gov/pubmed/27708579 http://dx.doi.org/10.3389/fphar.2016.00316

Ejemplares similares

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
por: Agúndez, José A. G., et al.
Publicado: (2022)

Asthma and Rhinitis Induced by Selective Immediate Reactions to Paracetamol and Non-steroidal Anti-inflammatory Drugs in Aspirin Tolerant Subjects
por: Pérez-Alzate, Diana, et al.
Publicado: (2016)

Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug–Induced Acute Urticaria/Angioedema
por: Jurado-Escobar, Raquel, et al.
Publicado: (2021)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2023)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
por: Macías, Yolanda, et al.
Publicado: (2021)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
por: Garcia-Agundez, Augusto, et al.
Publicado: (2022)

Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
por: Agúndez, José A. G., et al.
Publicado: (2014)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
por: Garcia-Agundez, Augusto, et al.
Publicado: (2023)

Platelet-Adherent Leukocytes Associated With Cutaneous Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs
por: Jurado-Escobar, Raquel, et al.
Publicado: (2020)

FCERI and Histamine Metabolism Gene Variability in Selective Responders to NSAIDS
por: Amo, Gemma, et al.
Publicado: (2016)

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
por: Agúndez, José A. G., et al.
Publicado: (2012)

Prostaglandins, Leukotrienes, and the Immune Response
por: Ratcliff, Brad
Publicado: (1989)

Mitochondria-targeted antioxidant SkQ1 inhibits leukotriene synthesis in human neutrophils
por: Sud’ina, Galina F., et al.
Publicado: (2022)

Leukotrienes in Tumor-Associated Inflammation
por: Tian, Wen, et al.
Publicado: (2020)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
por: Rytkin, Eric, et al.
Publicado: (2023)

Evaluation of Subjects Experiencing Allergic Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Characteristics and Drugs Involved
por: Pérez-Sánchez, Natalia, et al.
Publicado: (2020)

Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis
por: Zhao, Yuxuan, et al.
Publicado: (2022)

Dysregulation of prostaglandins, leukotrienes and lipoxin A(4) in bronchiectasis
por: Bedi, Pallavi, et al.
Publicado: (2022)

Detoxifying Enzymes at the Cross-Roads of Inflammation, Oxidative Stress, and Drug Hypersensitivity: Role of Glutathione Transferase P1-1 and Aldose Reductase
por: Sánchez-Gómez, Francisco J., et al.
Publicado: (2016)

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy
por: García-Menaya, Jesús Miguel, et al.
Publicado: (2019)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Identification of Novel Biomarkers for Drug Hypersensitivity After Sequencing of the Promoter Area in 16 Genes of the Vitamin D Pathway and the High-Affinity IgE Receptor
por: Amo, Gemma, et al.
Publicado: (2019)

Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012)

Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)

Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
por: Borràs, Emma, et al.
Publicado: (2011)

Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy
por: Belizário, José E., et al.
Publicado: (2016)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital
por: García-Menaya, Jesús Miguel, et al.
Publicado: (2020)

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
por: Dixon, Eleanor Grace, et al.
Publicado: (2021)

Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Editorial: Pharmacogenomics in neglected populations
por: Botton, Mariana R., et al.
Publicado: (2022)

Pharmacogenomics in clinical trials: an overview
por: Nogueiras-Álvarez, Rita
Publicado: (2023)

Prostaglandin E(2) Impairs P2Y(2)/P2Y(4) Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors
por: Paniagua-Herranz, Lucía, et al.
Publicado: (2017)

Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Leukotriene D(4)-induced Caco-2 cell proliferation is mediated by prostaglandin E(2) synthesis
por: Cabral, Marisol, et al.
Publicado: (2015)

Pharmacogenomics of human P450 oxidoreductase
por: Pandey, Amit V., et al.
Publicado: (2014)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Current clinical evidence on pioglitazone pharmacogenomics
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k1arnevndpcq7csasvef0nkqk5